For this purpose, we evaluated membrane-bound and secreted fractions of CrkL in human cancer cell lines and clinical tissue and blood serum samples from breast cancer patients with early and advanced disease, as well as healthy donors. This evidence concerns the gene CRKL and breast cancer.